PCM
CORZ icon

Portolan Capital Management’s Core Scientific CORZ Stock Holding History

Portolan Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,025,508
Closed -$14.4M – 120
2024
Q4 		$14.4M Buy
1,025,508
+473,531
+86% +$7M 0.97% 32
2024
Q3 		$6.55M Buy
+551,977
New +$5.72M 0.47% 73

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

Portolan Capital Management's CORZ Position: Q1 2025 in Review

Portolan Capital Management sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 1,025,508 shares — an estimated $14.4M sold.

Portolan Capital Management first reported a position in CORZ in Q3 2024 and held it in 2 quarters. The position peaked at $14.4M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

  • Portolan Capital Management reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
  • Portolan Capital Management sold 1,025,508 Core Scientific shares in Q1 2025, an estimated $14.4M.
  • Portolan Capital Management first reported a position in Core Scientific in Q3 2024 and held it in 2 quarters.
  • Portolan Capital Management's Core Scientific position peaked at $14.4M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Portolan Capital Management's 13F filing for Q1 2025, filed 15 May 2025.